OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
September 22, 2021
Lonza’s investment in its Stein and Basel facilities in Switzerland aims to expand its overall drug product development and manufacturing services.
September 16, 2021
The COVID-19 pandemic has further impacted ongoing drug shortage issues; essential action is needed to avoid repeating previous mistakes.
August 31, 2021
USAntibiotics will serve as the sole American-based provider of amoxicillin and amoxil clavulanate.
August 18, 2021
The Cleveland, Ohio facility will produce critical anti-infective drug products for US hospitals.
August 17, 2021
Syngene’s additions include a new microbial facility and an expanded mammalian facility.
August 13, 2021
Almac Sciences has signed a manufacturing agreement with Pila Pharma for the production of the API XEN-D0501.
Recro acquires CDMO IRISYS, establishing a bi-coastal presence in the US.
August 12, 2021
Veraxa and Indivumed will work together to develop colorectal antibody drugs.
August 09, 2021
Kyowa Pharmaceutical Industry and Bora Pharmaceuticals have announced a partnership to produce generic-drug product for filing in Japan.
August 06, 2021
Syngene International appoints two US-based executives to senior level positions.